Amphotec
NDC Package 66435-302-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Amphotec is a . Marketed by Kadmon Pharmaceuticals Llc, this product is identified by NDC 66435-302 and is authorized under FDA application NDA050729.

Identification & Billing

NDC Package Code
66435-302-01
Package Description
1 VIAL, SINGLE-USE in 1 CARTON / 100 mg in 1 VIAL, SINGLE-USE
Product Code
66435-302
11-Digit Billing Format
66435030201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Amphotec
Dosage Form
-

Regulatory & Marketing

Labeler Name
Kadmon Pharmaceuticals Llc
FDA Application #
NDA050729
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-20-2005
End Marketing Date
05-31-2011
Listing Expiration
05-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66435-302-01 identifies a specific commercial package of 1 vial, single-use in 1 carton / 100 mg in 1 vial, single-use of Amphotec, labeled by Kadmon Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kadmon Pharmaceuticals Llc on May 20, 2005. The current certification is valid through May 31, 2011.

How is this Kadmon Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66435030201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66435-302-01
11-Digit CMS (5-4-2)
66435-0302-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.